Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition

Jan A. Burger(The University of Texas MD Anderson Cancer Center), Catherine J. Wu(Broad Institute)

Nature Communications

May 20, 2016

10.1038/ncomms11589

Cited by 345

Related Papers

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

|Blood|2005|1.2k

Towards personalized, tumour-specific, therapeutic vaccines for cancer

|Nature reviews. Immunology|2017|1k

Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1

|Blood|2000|732

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

|Blood|2009|576

Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

|Blood|2009|142